XNYS · Healthcare · Medical Devices
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
Leadership reshuffling in key divisions signals strategic pivot as medical device giant navigates margin pressures despite **$9.8B revenue beat** and strong positioning in growing vascular/wound care markets.
AI-generated summary — powered by BigEarnings.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | Q4 2026 | 1.55 | 1.55 | +0.00% | $9.81B | ➖ Inline | — | — | — |
| 2026-02-17 | Q3 2026 | 1.33 | 1.36 | +2.26% | $9.02B | ✅ Beat | +2.16% | +0.35% | -9.90% |
| 2025-11-18 |
| Q2 2026 |
| 1.31 |
| 1.36 |
| +3.82% |
| $8.96B |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-19 | Q1 2026 | 1.23 | 1.26 | +2.44% | $8.58B | ✅ Beat | +1.82% | +2.54% | +6.33% |
| 2025-05-21 | Q4 2025 | 1.58 | 1.62 | — | $8.93B | ✅ Beat | — | — | — |
| 2025-02-18 | Q3 2025 | 1.36 | 1.39 | +2.21% | $8.29B | ✅ Beat | — | — | — |
| 2024-11-19 | Q2 2025 | 1.25 | 1.26 | +0.80% | $8.40B | ✅ Beat | — | — | — |
| 2024-08-20 | Q1 2025 | 1.20 | 1.23 | +2.50% | $7.92B | ✅ Beat | — | — | — |
Showing last 8 quarters.